Center-Authored Papers

Filters: Author is Fan, Jian-Bing  [Clear All Filters]
G
Geybels MS, Wright JL, Bibikova M, Klotzle B, Fan J-B, Zhao S, Feng Z, Ostrander EA, Lin DW, Nelson PS et al..  2016.  Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy.. Clinical epigenetics. 8:97. Abstract
Geybels MS, Zhao S, Wong C-J, Bibikova M, Klotzle B, Wu M, Ostrander EA, Fan J-B, Feng Z, Stanford JL.  2015.  Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue.. The Prostate. 75(16):1941-50. Abstract
Geybels MS, Alumkal JJ, Luedeke M, Rinckleb A, Zhao S, Shui IM, Bibikova M, Klotzle B, van den Brandt PA, Ostrander EA et al..  2015.  Epigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion-positive versus fusion-negative tumors.. Clinical epigenetics. 7:128. Abstract
J
Jhun MA, Geybels MS, Wright JL, Kolb S, April C, Bibikova M, Ostrander EA, Fan J-B, Feng Z, Stanford JL.  2017.  Gene expression signature of Gleason score is associated with prostate cancer outcomes in a radical prostatectomy cohort.. Oncotarget. Abstract
P
Perez EA, Thompson AE, Ballman KV, Anderson KS, Asmann YW, Kalari KR, Eckel-Passow JE, Dueck AC, Tenner KS, Jen J et al..  2015.  Genomic analysis reveals that immune function genes are strongly linked to clinical outcome in the North Central Cancer Treatment Group n9831 Adjuvant Trastuzumab Trial.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 33(7):701-8. Abstract
R
Rubicz R, Zhao S, Geybels M, Wright JL, Kolb S, Klotzle B, Bibikova M, Troyer D, Lance R, Ostrander EA et al..  2016.  DNA methylation profiles in African American prostate cancer patients in relation to disease progression.. Genomics. Abstract
Rubicz R, Zhao S, April C, Wright JL, Kolb S, Coleman I, Lin DW, Nelson PS, Ostrander EA, Feng Z et al..  2015.  Expression of cell cycle-regulated genes and prostate cancer prognosis in a population-based cohort.. The Prostate. Abstract
Rubicz R, Zhao S, Wright JL, Coleman I, Grasso C, Geybels MS, Leonardson A, Kolb S, April C, Bibikova M et al..  2017.  Gene expression panel predicts metastatic-lethal prostate cancer outcomes in men diagnosed with clinically localized prostate cancer.. Molecular oncology. 11(2):140-150. Abstract
S
Shui IM, Wong C-J, Zhao S, Kolb S, Ebot EM, Geybels MS, Rubicz R, Wright JL, Lin DW, Klotzle B et al..  2016.  Prostate tumor DNA methylation is associated with cigarette smoking and adverse prostate cancer outcomes.. Cancer. 122(14):2168-77. Abstract
Stott-Miller M, Zhao S, Wright JL, Kolb S, Bibikova M, Klotzle B, Ostrander EA, Fan J-B, Feng Z, Stanford JL.  2014.  Validation study of genes with hypermethylated promoter regions associated with prostate cancer recurrence.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 23(7):1331-9. Abstract
Z
Zhao S, Leonardson A, Geybels MS, McDaniel AS, Yu M, Kolb S, Zong H, Carter K, Siddiqui J, Cheng A et al..  2018.  A five-CpG DNA methylation score to predict metastatic-lethal outcomes in men treated with radical prostatectomy for localized prostate cancer.. The Prostate. Abstract
Zhao S, Geybels MS, Leonardson A, Rubicz R, Kolb S, Yan Q, Klotzle B, Bibikova M, Hurtado-Coll A, Troyer D et al..  2016.  Epigenome-wide Tumor DNA Methylation Profiling Identifies Novel Prognostic Biomarkers of Metastatic-lethal Progression in Men with Clinically Localized Prostate Cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research. Abstract